{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:30:47Z","timestamp":1787758247378,"version":"build-2784847793"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Acute kidney injury (AKI) is a presentation of an underlying heterogeneous group of conditions that leads to impairment of filtration and excretion of nitrogenous waste products from the body. A prompt early diagnosis to detect AKI is a mandate due to the associated risk of high mortality and morbidity. We tested the sensitivity and specificity of plasma neutrophil gelatinase-associated lipocalin (NGAL), a potential biomarker of AKI, versus serum creatinine, the gold standard laboratory test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A cross-sectional diagnostic type study was conducted from February 2015 to January 2017 after obtaining the institutional ethics clearance certificate. Individuals admitted to the intensive care unit (ICU) of a tertiary care hospital of northeast India who were diagnosed with septicemia, heart failure, and ketoacidosis and individuals on nephrotoxic drugs such as aminoglycosides were included in the study. Serum creatinine and plasma NGAL of all individuals were estimated using suitable methods within 24 h of admissions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Considering all inclusion and exclusion criteria, 138 individuals were included in the study. The area under the curve (AUC) for plasma NGAL on day 1 of admission was 0.800 (95% confidence interval [CI]: 0.712\u20130.882). In the study, we estimated a plasma NGAL cut-off value of 391 ng\/mL (with an odds ratio of 9.89) within the day of admission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Plasma NGAL is a candidate biomarker of AKI with acceptable sensitivity and specificity (AUC of 0.80) that can predict AKI in our setup before serum creatinine is raised, thereby asking for a prompt intervention to reduce the mortality and morbidity associated with AKI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_2316_21","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T05:11:16Z","timestamp":1659330676000},"page":"3681-3686","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Plasma neutrophil gelatinase-associated lipocalin (NGAL)"],"prefix":"10.4103","volume":"11","author":[{"given":"Chandan Kr","family":"Nath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purnima","family":"Rajkhowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupen","family":"Barman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himesh","family":"Barman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Star","family":"Pala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaustubh","family":"Bora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faruque","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Boruah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arup","family":"Baruah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-46-20240828","first-page":"1482","article-title":"Acute kidney injury advisory group of the American society of nephrology","volume":"8","author":"Susantitaphong","year":"2013","journal-title":"World incidence of AKI:A meta-analysis. Clin J Am Soc Nephrol"},{"key":"R4-46-20240828","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/ncpneph0722","article-title":"The contrasting characteristics of acute kidney injury in developed and developing countries","volume":"4","author":"Cerd\u00e1","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"R5-46-20240828","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4103\/0972-5229.183904","article-title":"Acute kidney injury-incidence, prognostic factors, and outcome of patients in an Intensive Care Unit in a tertiary center:A prospective observational study","volume":"20","author":"Korula","year":"2016","journal-title":"Indian J Crit Care Med"},{"key":"R6-46-20240828","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/JLP.JLP_135_18","article-title":"Clinical profile and determinants of short-term outcome of acute kidney injury:A hospital-based prospective study from Northeastern India","volume":"11","author":"Bhattacharya","year":"2019","journal-title":"J Lab Physicians"},{"key":"R7-46-20240828","first-page":"LC05","article-title":"Acute kidney injury:Prevalence and outcomes in southern Indian population","volume":"12","author":"Mohammed","year":"2018","journal-title":"J Clin Diagn Res"},{"key":"R8-46-20240828","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2215\/CJN.03200314","article-title":"AKI in low-risk versus high-risk patients in intensive care","volume":"10","author":"Sileanu","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"R9-46-20240828","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","article-title":"Epidemiology of acute kidney injury in critically ill patients:The multinational AKI-EPI study","volume":"41","author":"Hoste","year":"2015","journal-title":"Intensive Care Med"},{"key":"R10-46-20240828","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12882-018-0824-6","article-title":"Incidence, aetiology and outcomes of obstetric-related acute kidney injury in Malawi:A prospective observational study","volume":"19","author":"Cooke","year":"2018","journal-title":"BMC Nephrol"},{"key":"R11-46-20240828","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1053\/j.ajkd.2014.10.018","article-title":"Risk factors for acute kidney injury in older adults with critical illness:A retrospective cohort study","volume":"65","author":"Kane-Gill","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"R12-46-20240828","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/ndt\/gfx026","article-title":"A risk prediction score for acute kidney injury in the intensive care unit","volume":"32","author":"Malhotra","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"R14-46-20240828","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s13054-016-1478-z","article-title":"Acute kidney injury. 2016:Diagnosis and diagnostic workup","volume":"20","author":"Ostermann","year":"2016","journal-title":"Crit Care"},{"key":"R15-46-20240828","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/MCC.0000000000000157","article-title":"Diagnosis of acute kidney injury:Kidney disease improving global outcomes criteria and beyond","volume":"20","author":"Ostermann","year":"2014","journal-title":"Curr Opin Crit Care"},{"key":"R16-46-20240828","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2215\/CJN.12191213","article-title":"Biomarkers of AKI:A review of mechanistic relevance and potential therapeutic implications","volume":"10","author":"Alge","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"R17-46-20240828","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/00365510802150158","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL):A new marker of kidney disease","volume":"241","author":"Devarajan","year":"2008","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"R18-46-20240828","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fcvm.2019.00156","article-title":"Hypoxia stimulates synthesis of neutrophil gelatinase-associated lipocalin in aortic valve disease","volume":"6","author":"Swaminathan","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"R19-46-20240828","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(05)74811-X","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery","volume":"365","author":"Mishra","year":"2005","journal-title":"Lancet"},{"key":"R20-46-20240828","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3109\/0886022X.2015.1033324","article-title":"Urine neutrophil gelatinase-associated lipocalin levels predict acute kidney injury in acute decompensated heart failure patients","volume":"37","author":"Soyler","year":"2015","journal-title":"Ren Fail"},{"key":"R21-46-20240828","first-page":"554","article-title":"Biomarkers in acute kidney injury-Pathophysiological basis and clinical performance","volume":"219","author":"Schrezenmeier","year":"2017","journal-title":"Acta Physiol (Oxf"},{"key":"R22-46-20240828","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1515\/cclm-2016-0973","article-title":"Biomarkers of acute kidney injury:The pathway from discovery to clinical adoption","volume":"55","author":"Kashani","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"R23-46-20240828","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.amjcard.2015.03.043","article-title":"Comparison of neutrophil gelatinase-associated lipocalin versus B-Type natriuretic peptide and cystatin C to predict early acute kidney injury and outcome in patients with acute heart failure","volume":"116","author":"Palazzuoli","year":"2015","journal-title":"Am J Cardiol"},{"key":"R24-46-20240828","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/cc6162","article-title":"N-GAL:Diagnosing AKI as soon as possible","volume":"11","author":"Ronco","year":"2007","journal-title":"Crit Care"},{"key":"R25-46-20240828","first-page":"197","article-title":"Neutrophil gelatinase-associated lipocalin:A novel biomarker for the early diagnosis of acute kidney injury in the emergency department","volume":"13","author":"Di Grande","year":"2009","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R26-46-20240828","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/eurjhf\/hfr087","article-title":"Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure:The NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial","volume":"13","author":"Maisel","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"R27-46-20240828","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/ndt\/gfl408","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine and eGFR in patients with normal serum creatinine undergoing coronary angiography","volume":"22","author":"Bachorzewska-Gajewska","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R28-46-20240828","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/IJNRD.S45523","article-title":"Correlation of serum neutrophil gelatinase-associated lipocalin with acute kidney injury in hypertensive disorders of pregnancy","volume":"6","author":"Patel","year":"2013","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"R29-46-20240828","doi-asserted-by":"crossref","first-page":"e16867","DOI":"10.1097\/MD.0000000000016867","article-title":"Development of a risk stratification-based model for prediction of acute kidney injury in critically ill patients","volume":"98","author":"Chen","year":"2019","journal-title":"Medicine (Baltimore"},{"key":"R30-46-20240828","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12882-015-0003-y","article-title":"Influence of severity of illness on neutrophil gelatinase-associated lipocalin performance as a marker of acute kidney injury:A prospective cohort study of patients with sepsis","volume":"16","author":"Vanmassenhove","year":"2015","journal-title":"BMC Nephrol"},{"key":"R31-46-20240828","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/ph14090843","article-title":"Utility of suPAR and NGAL for AKI risk stratification and early optimization of renal risk medications among older patients in the emergency department","volume":"14","author":"Walls","year":"2021","journal-title":"Pharmaceuticals (Basel"},{"key":"R33-46-20240828","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1016\/j.ekir.2021.09.005","article-title":"Elevated neutrophil gelatinase-associated lipocalin is associated with the severity of kidney injury and poor prognosis of patients with COVID-19","volume":"6","author":"Xu","year":"2021","journal-title":"Kidney Int Rep"},{"key":"R34-46-20240828","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/ckj\/sfx087","article-title":"Angiotensinogen as a biomarker of acute kidney injury","volume":"10","author":"Aqeel Ba","year":"2017","journal-title":"Clin Kidney J"},{"key":"R35-46-20240828","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/cc12503","article-title":"Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury","volume":"17","author":"Kashani","year":"2013","journal-title":"Crit Care"},{"key":"R36-46-20240828","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/CCM.0b013e318169245a","article-title":"Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock","volume":"36","author":"Wheeler","year":"2008","journal-title":"Crit Care Med"},{"key":"R37-46-20240828","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.avsg.2010.01.001","article-title":"Neutrophil gelatinase associated lipocalin as a biomarker for acute kidney injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass","volume":"24","author":"Prabhu","year":"2010","journal-title":"Ann Vasc Surg"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_2316_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:07:50Z","timestamp":1787756870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_2316_21"}},"subtitle":["A candidate biomarker to detect early acute kidney injury (AKI) for at-risk intensive care admissions"],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_2316_21","relation":{},"ISSN":["2249-4863"],"issn-type":[{"value":"2249-4863","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}